Market Overview:
The global Bardoxolone Methyl market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of chronic diseases, increasing R&D expenditure by pharmaceutical companies, and growing demand for Bardoxolone Methyl in the medical sector. However, stringent regulatory norms and high cost of Bardoxolone Methyl are some of the major factors that are restraining the growth of this market. The global Bardoxolone Methyl market is segmented on the basis of type, application, and region. On the basis of type, it is divided into min purity less than 98%, min purity 98%-99%, and min purity more than 99%. By application, it is classified into research and medical sectors. Geographically, it is analyzed across North America (U.S., Canada), Latin America (Mexico), Europe (Germany France Italy Spain U.K.), Asia Pacific (China Japan India South Korea Australia New Zealand), Middle East & Africa (GCC Countries Turkey Nigeria South Africa).
Product Definition:
Bardoxolone methyl is a synthetic, orally active, pleiotropic agent that exhibits anti-inflammatory and antioxidative activities. It has been shown to improve the function of the heart, lungs, and kidneys in patients with chronic kidney disease (CKD) and heart failure.
Min Purity Less Than 98%:
Bardoxolone Methyl is a type of drug that is used for the treatment of cancer. It works by blocking the ability of cancer cells to grow and multiply. Bardoxolone Methyl has low toxicity levels, which makes it suitable for use in oncology treatments.
The global market size was valued at USD 817 million in 2016.
Min Purity 98%-99%:
Min Purity 98%-99% is a type of Pharmaceutical-grade Lactose. It has the same chemical and physical properties as regular lactose but at a lower concentration (range 97%-98%). Bardoxolone Methyl, manufactured by Roquette Pharma, uses this product as an excipient.
This helps in reducing the side effects caused due to high drug dosage.
Application Insights:
Medical application of bardoxolone methyl dominated the global market in terms of revenue share in 2017. Bardoxolone methyl is used for treating breast cancer, prostate cancer, testicular cancer and other cancers. It is also used for various other medical conditions such as endometriosis and polycystic ovary syndrome (PCOS). The high usage rate of bardoxolone methyl in the treatment of various cancers coupled with its growing use for the treatment of endometriosis and PCOS is expected to drive growth during the forecast period.
The research segment accounted for a significant share on account of extensive R&D initiatives undertaken by major manufacturers to develop new products that can offer enhanced benefits over existing products.
Regional Analysis:
North America dominated the global market in 2017. The growth is attributed to the presence of major pharmaceutical companies that are engaged in extensive R&D for new drug development. Moreover, increasing prevalence of osteoporosis and growing geriatric population are expected to drive bardoxolone methyl demand over the forecast period. In addition, stringent regulatory framework governing drug manufacturing processes is also anticipated to propel product demand over the forecast period.
Asia Pacific accounted for a significant share owing to high unmet clinical needs coupled with rapidly improving healthcare infrastructure in emerging economies such as China and India.
China was one of largest markets for Bardoxolone Methyl globally accounting for more than 50% share due its large geriatric population base which requires long term treatment options other than bone density-increasing drugs like Fosamax or Actonel (risedronate).
Growth Factors:
- Increasing prevalence of chronic kidney diseases (CKD) and diabetes mellitus (DM)
- Growing geriatric population
- Rising awareness about the benefits of Bardoxolone Methyl therapy
- Technological advancements in renal dialysis therapies
- Availability of government funding for research and development activities in the field of nephrology
Scope Of The Report
Report Attributes
Report Details
Report Title
Bardoxolone Methyl Market Research Report
By Type
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
By Application
Research, Medical
By Companies
Abcam, Santa Cruz Biotechnology, Cayman Chemical, Selleck Chemicals, AbMole, Bio-Techne, LifeSpan BioSciences, LGC, Merck, Shimadzu, Biosynth Carbosynth, Biorbyt, Aladdin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
219
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global Bardoxolone Methyl Market Report Segments:
The global Bardoxolone Methyl market is segmented on the basis of:
Types
Min Purity Less Than 98%, Min Purity 98%-99%, Min Purity More Than 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam
- Santa Cruz Biotechnology
- Cayman Chemical
- Selleck Chemicals
- AbMole
- Bio-Techne
- LifeSpan BioSciences
- LGC
- Merck
- Shimadzu
- Biosynth Carbosynth
- Biorbyt
- Aladdin
Highlights of The Bardoxolone Methyl Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Min Purity Less Than 98%
- Min Purity 98%-99%
- Min Purity More Than 99%
- By Application:
- Research
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bardoxolone Methyl Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bardoxolone methyl is a corticosteroid medication used to treat various conditions, including asthma, dermatitis, and joint pain. It works by reducing inflammation and swelling in the body.
Some of the major players in the bardoxolone methyl market are Abcam, Santa Cruz Biotechnology, Cayman Chemical, Selleck Chemicals, AbMole, Bio-Techne, LifeSpan BioSciences, LGC, Merck, Shimadzu, Biosynth Carbosynth, Biorbyt, Aladdin.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bardoxolone Methyl Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Bardoxolone Methyl Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Bardoxolone Methyl Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Bardoxolone Methyl Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Bardoxolone Methyl Market Size & Forecast, 2020-2028 4.5.1 Bardoxolone Methyl Market Size and Y-o-Y Growth 4.5.2 Bardoxolone Methyl Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Min Purity Less Than 98%
5.2.2 Min Purity 98%-99%
5.2.3 Min Purity More Than 99%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bardoxolone Methyl Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bardoxolone Methyl Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Min Purity Less Than 98%
9.6.2 Min Purity 98%-99%
9.6.3 Min Purity More Than 99%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Min Purity Less Than 98%
10.6.2 Min Purity 98%-99%
10.6.3 Min Purity More Than 99%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Min Purity Less Than 98%
11.6.2 Min Purity 98%-99%
11.6.3 Min Purity More Than 99%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Min Purity Less Than 98%
12.6.2 Min Purity 98%-99%
12.6.3 Min Purity More Than 99%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Min Purity Less Than 98%
13.6.2 Min Purity 98%-99%
13.6.3 Min Purity More Than 99%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bardoxolone Methyl Market: Competitive Dashboard
14.2 Global Bardoxolone Methyl Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam
14.3.2 Santa Cruz Biotechnology
14.3.3 Cayman Chemical
14.3.4 Selleck Chemicals
14.3.5 AbMole
14.3.6 Bio-Techne
14.3.7 LifeSpan BioSciences
14.3.8 LGC
14.3.9 Merck
14.3.10 Shimadzu
14.3.11 Biosynth Carbosynth
14.3.12 Biorbyt
14.3.13 Aladdin